Effect of prophylactic corticosteroid treatment on adeno-associated virus (AAV)-mediated gene expression

被引:0
|
作者
Handyside, B. [1 ]
Zhang, L. [1 ]
Yates, B. [1 ]
Xie, L. [1 ]
Sihn, C. R. [1 ]
Liu, S. [1 ]
Bouwman, T. [1 ]
Kaplowitz, B. [1 ]
Razon, L. [1 ]
Gorostiza, O. [1 ]
Murphy, R. [1 ]
Fredette, N. [1 ]
Baridon, B. [1 ]
Ngo, K. [1 ]
Siso, S. [1 ]
Agrawal, V. [1 ]
Cortesio, C. [1 ]
Akeefe, H. [1 ]
Woloszynek, J. [1 ]
Zhang, W. [1 ]
Su, C. [1 ]
Colosi, P. [1 ]
Bullens, S. [1 ]
Veres, G. [1 ]
Bunting, S. [1 ]
Fong, S. [1 ]
机构
[1] BioMarin Pharmaceut, Novato, CA USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
P333
引用
收藏
页码:A130 / A131
页数:2
相关论文
共 50 条
  • [1] The Effect of Prophylactic Corticosteroid Treatment on Adeno-Associated Virus (AAV)-Mediated Gene Expression
    Handyside, Britta
    Zhang, Lening
    Yates, Bridget
    Xie, Lin
    Kaplowitz, Brian
    Gorostiza, Olivia
    Murphy, Ryan
    Fredette, Natalie
    Baridon, Brian
    Ngo, Katina
    Siso, Silvia
    Agrawal, Vishal
    Cortesio, Christa
    Akeefe, Hassib
    Woloszynek, Jill
    Zhang, Weiming
    Su, Cheng
    Colosi, Peter
    Bullens, Sherry
    Veres, Gabor
    Bunting, Stuart
    Fong, Sylvia
    [J]. MOLECULAR THERAPY, 2021, 29 (04) : 167 - 167
  • [2] The Effect of Prophylactic Corticosteroid Treatment on Adeno-Associated Virus-Mediated Gene Therapy and Potential Mechanisms of Action
    Handyside, Britta
    Zhang, Lening
    Yates, Bridget
    Xie, Lin
    Sihn, Choong-Ryoul
    Murphy, Ryan
    Bouwman, Taren
    Baridon, Brian
    Ngo, Katina
    Su, Cheng
    Colosi, Peter
    Bullens, Sherry
    Ismail, Ashrafali M.
    Bunting, Stuart
    Fong, Sylvia
    [J]. MOLECULAR THERAPY, 2022, 30 (04) : 444 - 445
  • [3] Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
    Naso, Michael F.
    Tomkowicz, Brian
    Perry, William L., III
    Strohl, William R.
    [J]. BIODRUGS, 2017, 31 (04) : 317 - 334
  • [4] Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
    Michael F. Naso
    Brian Tomkowicz
    William L. Perry
    William R. Strohl
    [J]. BioDrugs, 2017, 31 : 317 - 334
  • [5] Adeno-associated virus (AAV) vectors in gene therapy
    Serra, C
    Zentilin, L
    Tafuro, S
    Falaschi, A
    Giacca, M
    [J]. MINERVA BIOTECNOLOGICA, 1997, 9 (03) : 155 - 165
  • [6] Application of aav (adeno-associated virus) to gene therapy
    Ozawa, Keiya
    [J]. JOURNAL OF GENE MEDICINE, 2008, 10 (04): : 436 - 436
  • [7] Effective inhibition of specific gene by adeno-associated virus (AAV)-mediated expression of small interfering RNA
    Yin, Jun
    Zhang, Yumei
    Yang, Ling
    Li, Houda
    Xue, Zhengfeng
    [J]. AFRICAN JOURNAL OF BIOTECHNOLOGY, 2011, 10 (15): : 2844 - 2849
  • [8] ADENO-ASSOCIATED VIRUS (AAV) - A VECTOR FOR STABLE INTEGRATION AND EXPRESSION OF A FOREIGN GENE
    TRATSCHIN, JD
    SMITH, M
    MILLER, IL
    CARTER, BJ
    [J]. EXPERIENTIA, 1985, 41 (06): : 813 - 813
  • [9] Retrograde gene transfer into neural pathways mediated by adeno-associated virus (AAV)-AAV receptor interaction
    Sano, Hiromi
    Kobayashik, Kenta
    Yoshioka, Nozomu
    Takebayashi, Hirohide
    Nambu, Atsushi
    [J]. JOURNAL OF NEUROSCIENCE METHODS, 2020, 345
  • [10] Inhibition of choroidal Neovascularization (CNV) by adeno-associated virus (AAV) mediated expression of PEDF
    Wang, F
    Shi, G
    Rendahl, KG
    Manning, WC
    Jafari, A
    Liu, W
    Coyne, M
    Miller, SS
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U281 - U281